Where to buy Bimekizumab

Bimekizumab is a drug used to treat moderate to severe plaque psoriasis (a skin disease that causes red, scaly patches on certain parts of the body) in some adults. Although many biologics are currently available to treat psoriasis, some patients may develop resistance to other treatments and/or develop psoriasis flares during or after drug withdrawal. In this context, bimeclizumab may be another valuable option for patients with moderate to severe psoriasis.

BimekizumabActive substancesBimekizumab is a monoclonal antibody, a protein designed to attach to the interleukins IL-17A, IL-17F and IL-17AF, which are messenger molecules in the body's immune system, the body's natural defense system. High levels of these interleukins have been shown to be associated with the development of inflammatory diseases caused by the immune system, such as plaque psoriasis, psoriatic arthritis, and axial spondyloarthritis. By attaching to these interleukins, bimeclizumab prevents them from interacting with receptors (targets) in the body, thereby reducing inflammation and improving symptoms associated with these diseases.

The generic drug Bimetizumab has not yet been launched in China, so it cannot be included in medical insurance. Domestic patients cannot yet purchase this drug. The European version of bimezumab original drug sold overseas, specifications160mg*2 per box may cost more than 40,000 yuan (the price may fluctuate due to the exchange rate). The price is still relatively high. There is currently no generic version of bimezumab produced and launched. For the specific price and drug information of this drug, please consult a medical consultant.